Site Network

How Regional Sites in a Global Site Network Combine Local Insight with Global Scale

Darin Brimhall, D.O., FACP

PPD clinical research business of Thermo Fisher Scientific

Clinical Diversity

Driving Diversity and Accessibility in Clinical Trials Starts at the Community Level

Melissa Choi, M.D.

Trialmed

Pathfinder

Surrogate Endpoints vs. Clinical Endpoints: Which Evidence Strategy Is Better for Drug Development?

Pharma's Almanac

Oncology

Harnessing Macrophage Biology to Overcome Tumor Immune Evasion

Roy Maute, Ph.D.

Pheast Therapeutics

Pathfinder

Basket vs. Umbrella Clinical Trials: Which Precision Oncology Trial Design Is Better?

Pharma's Almanac

Pathfinder

Adaptive Trials vs. Traditional Randomized Controlled Trials: Which Clinical Trial Design Is Better?

Pharma's Almanac

Basket Trials

Basket Trials and the Future of Rare Cancer Research

David Alvaro, Ph.D.

Pharma's Almanac

Pathfinder

Site-Based vs. Decentralized vs. Hybrid Clinical Trials: Which Model Is Best for Modern Clinical Research?

Pharma's Almanac

Adaptive Trials

Designing for Change: Adaptive Clinical Trials and the Evolving Path to Regulatory Acceptance

Pharma's Almanac

Expedited Pathways

Accelerated Pathways: Are They Delivering on Their Promise?

David Alvaro, Ph.D.

Pharma's Almanac

Clinical Evidence

Rethinking Clinical Evidence Requirements in Rare Diseases

David Alvaro, Ph.D.

Pharma's Almanac

Clinical Trial Needs

Bridging the Gap: Addressing Unmet Needs in Cardiology, Neuroscience, and Respiratory Trials

Bethany Davis, M.D.

Trialmed

Neuro Biomarkers

Precision Neurology: How Biomarkers Are Redefining Clinical Trial Design

David Alvaro, Ph.D.

Pharma's Almanac

CKD

The Expanding Therapeutic Landscape in Chronic Kidney Disease

David Alvaro, Ph.D.

Pharma's Almanac

Clinical Recruitment

Breaking Down Barriers in Cardiology Trials to Expand Access to At-Risk Populations

Karen Faulkner, M.D.; Madhu Venkate Gowda, M.D.

Trialmed

Early-Phase Trials

Innovations in Early-Phase Clinical Trials: Pioneering the Future of Medicine

Craig Boyle. M.D.

Trialmed

GCP

How Fully Owned, Locally Led Site Networks Deliver Quality, Speed, and Scalability in the Era of ICH E6(R3)

Łukasz Wiech, MD, MBA

Trialmed